Microport Cardioflow Medtech (2160.HK) Stock Price

Microport Cardioflow Medtech Price

HKEX·CLOSED
1.09
​
Market closed

Revenue has compounded at 75.8% per year over the past 5 years to 361.57 M CNY. Microport Cardioflow Medtech's net margin stands at -13.7%, up from -383.0% several years earlier. Analysts set a median price target of 1.30 CNY, implying 19.5% above the current price. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.

Microport Cardioflow Medtech stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Microport Cardioflow Medtech business model & stock analysis

MicroPort CardioFlow Medtech Corp. develops and commercializes transcatheter and surgical solutions for valvular heart diseases, primarily focusing on the domestic market. The company's main products are the first-generation TAVI product VitaFlow and the second-generation TAVI product VitaFlow II, which are used for transcatheter aortic heart valve implantation. These products are sold to healthcare providers and hospitals within China, where the company operates under its holding company structure. The firm generates revenue through the sale of its medical devices, specifically the VitaFlow and VitaFlow II systems, targeting hospitals and medical institutions that require advanced cardiac solutions. As a domestic-focused entity, MicroPort CardioFlow's business model relies on the commercialization of its TAVI products within China's healthcare sector, with no mention of international markets or additional product lines beyond the two TAVI systems.

Frequently asked questions about Microport Cardioflow Medtech

Analysts currently set an average price target of 1.30 CNY for the Microport Cardioflow Medtech stock (median: 1.30 CNY), implying +19.5 % versus the latest price. The consensus is based on 8 analyst ratings.

8 analysts currently rate the Microport Cardioflow Medtech stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Microport Cardioflow Medtech to generate revenue of 266.96 M CNY and earnings per share of -0.01 CNY.

Converted at the current exchange rate, the Microport Cardioflow Medtech share trades at 0.15 EUR (1.09 CNY).

The Microport Cardioflow Medtech share (2160.HK) is listed on 4 stock exchanges, including: Hongkong (HKEX) (2160.HK), Frankfurt (72X.F), München (72X.MU), Düsseldorf (72X.DU).

The expected revenue of Microport Cardioflow Medtech is 266.96 M CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Microport Cardioflow Medtech is -5.57 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Microport Cardioflow Medtech is currently -91.35. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Microport Cardioflow Medtech stock.

The price-to-sales ratio (P/S) of Microport Cardioflow Medtech is currently 1.90. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Microport Cardioflow Medtech stock.

The Eulerpool Quality Score for Microport Cardioflow Medtech is 3/10.

The ISIN of Microport Cardioflow Medtech is KYG6082P1211. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Microport Cardioflow Medtech is A2QML9. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Microport Cardioflow Medtech is 2160.HK. The ticker symbol is used to trade Microport Cardioflow Medtech shares on the stock exchange.

Fair ValueTerminal
0.93 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
624,464.59 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CNY
Initial public offering
Feb 4, 2021
ISIN
KYG6082P1211
Cusip
G6082P105
Market capitalization
508.40 M CNYSmall Cap
52-Week Range
PEG
0.16
P/E ratio
P/Ee 2025
-12.04
P/Ee 2026
-91.35
P/Ee 2027
-272.80
P/Ee 2028
—
P/Ee 2029
—
P/S
P/Se
1.29
EV/EBIT
—
P/B Ratio
0.23
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-2.18 %
Last updated Nov 4, 2026, 9:00 AM

Microport Cardioflow Medtech Peer Group

Microport Cardioflow Medtech Ticker

DÜSSELDORF · 72X.DUFRANKFURT · 72X.FHKEX · 2160.HKMUNICH · 72X.MU

Microport Cardioflow Medtech FIGI

2160:HK · BBG00Y4744W772X:TH · BBG00Z4LW47072X:GR · BBG00Z5H256972X:GF · BBG00Z5H257872X:GD · BBG00Z5H258772X:GS · BBG00Z5H25C272X:GM · BBG00Z5H25D12160EUR:XS · BBG00Z61SSV72160EUR:XH · BBG00Z61SSY42160EUR:XF · BBG00Z61ST092160EUR:XE · BBG00Z61ST272160EUR:XL · BBG00Z61ST45